Ashish M. Kamat, MD, MBBS Profile picture
Endowed Professor, Surgeon, Former Fellowship Director @MDAndersonNews | President, IBCG | Assoc Editor @EurUrolOncol | Views my own

Jan 21, 2023, 11 tweets

Help our debaters prep with your responses
Poll #1a: Does PDD/NBI etc help alter natural history of NMIBC?

@joanfundi @MarekBabjuk

Poll #1b: Do we still need random biopsies in era of PDD/NBI?

@MarekBabjuk @joanfundi

Poll #2: Should we be switching to en block TURBT for all bladder tumors?

#bladdercancer @paolo_gontero @JoshMeeks @bbmdmsk @joanfundi @MarekBabjuk @joostboormans @spsutkaMD @siadaneshmand @jteoh_hk

Poll #3b: in above scenario; does variant histology change your recommendation? (assume micropapillary, 15% specimen)

@priyaraomd @MaxKates @SWilliams_MD @WesKassouf @JanetKukreja @Agarwal_CaB @PatrickKenneyMD @evacomperat @h_alahmadie @MattGalsky

Poll #4a: In young healthy patient, is prostate sparing radical cystectomy a safe option for MIBC?

@angiesmith_uro @ParamMariappan @RenuEapen @Svet_MD @garysteinbergmd @JimCatto @uretericbud #bladdercancer @bcan_chisolm

Poll #6: Is there a role for local therapy to the bladder in patients with oligometastatic disease?

@AndreaNecchi @EfstathiouEleni @nnavai @UroCancer @PGrivasMDPhD @siadaneshmand @bbmdmsk @MarekBabjuk @joanfundi @MRoupret @mouwlab @Prof_Nick_James @achoud72 @drtanws

Share this Scrolly Tale with your friends.

A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.

Keep scrolling